{"id":"https://openalex.org/W1546909751","doi":"https://doi.org/10.1002/cncr.11882","title":"Chemotherapy\u2010induced neutropenia: Risks, consequences, and new directions for its management","display_name":"Chemotherapy\u2010induced neutropenia: Risks, consequences, and new directions for its management","publication_year":2004,"publication_date":"2004-01-05","ids":{"openalex":"https://openalex.org/W1546909751","doi":"https://doi.org/10.1002/cncr.11882","mag":"1546909751","pmid":"https://pubmed.ncbi.nlm.nih.gov/14716755"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.11882","doi":"https://doi.org/10.1002/cncr.11882","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11882","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11882","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1546909751"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11882","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037771704","display_name":"Jeffrey Crawford","orcid":"https://orcid.org/0000-0002-1274-1354","observed_orcids":["https://orcid.org/0000-0002-1274-1354"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey Crawford","raw_affiliation_strings":["Divisions of Oncology and Hematology, Duke University Medical Center, PO Box 25178 Morris Building, Durham, NC 27710-0001, USA. crawf006@mc.duke.edu","Divisions of Oncology and Hematology, Duke University Medical Center, Durham, North Carolina","Dr. Crawford and Dr. Dale receive research support from and are consultants for Amgen Inc. and also are members of its Speakers' Bureau"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Oncology and Hematology, Duke University Medical Center, PO Box 25178 Morris Building, Durham, NC 27710-0001, USA. crawf006@mc.duke.edu","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Divisions of Oncology and Hematology, Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Dr. Crawford and Dr. Dale receive research support from and are consultants for Amgen Inc. and also are members of its Speakers' Bureau","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015520404","display_name":"David C. Dale","orcid":"https://orcid.org/0000-0002-7146-1440","observed_orcids":["https://orcid.org/0000-0002-7146-1440"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David C. Dale","raw_affiliation_strings":["Department of Medicine, University of Washington, Seattle, Washington","Dr. Crawford and Dr. Dale receive research support from and are consultants for Amgen Inc. and also are members of its Speakers' Bureau"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Washington, Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Dr. Crawford and Dr. Dale receive research support from and are consultants for Amgen Inc. and also are members of its Speakers' Bureau","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073060840","display_name":"Gary H. Lyman","orcid":"https://orcid.org/0000-0002-0823-8086","observed_orcids":["https://orcid.org/0000-0002-0823-8086"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary H. Lyman","raw_affiliation_strings":["Dr. Lyman receives grant support from Amgen Inc. and is a member of its Speakers' Bureau","James P. Wilmont Cancer Center, University of Rochester Medical Center, Rochester, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Lyman receives grant support from Amgen Inc. and is a member of its Speakers' Bureau","institution_ids":[]},{"raw_affiliation_string":"James P. Wilmont Cancer Center, University of Rochester Medical Center, Rochester, New York","institution_ids":["https://openalex.org/I28792581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5037771704"],"corresponding_institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":2.7147,"has_fulltext":true,"cited_by_count":914,"citation_normalized_percentile":{"value":0.92436975,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"100","issue":"2","first_page":"228","last_page":"237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myelosuppressive-chemotherapy","display_name":"myelosuppressive chemotherapy","score":0.8880000114440918},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7979999780654907},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.6320000290870667},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.800000011920929},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8960338830947876},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7690109014511108},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.72847580909729},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6818736791610718},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5829137563705444},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3263792097568512}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003115","descriptor_name":"Colony-Stimulating Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.11882","doi":"https://doi.org/10.1002/cncr.11882","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11882","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11882","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:14716755","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14716755","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cncr.11882","doi":"https://doi.org/10.1002/cncr.11882","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11882","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11882","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1546909751.pdf","grobid_xml":"https://content.openalex.org/works/W1546909751.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W7334661","https://openalex.org/W117270364","https://openalex.org/W172411081","https://openalex.org/W584874934","https://openalex.org/W1641876683","https://openalex.org/W1868843221","https://openalex.org/W1885425707","https://openalex.org/W1907764344","https://openalex.org/W1932756735","https://openalex.org/W1933587402","https://openalex.org/W1990829116","https://openalex.org/W2002501169","https://openalex.org/W2014796166","https://openalex.org/W2025147742","https://openalex.org/W2036067444","https://openalex.org/W2044649990","https://openalex.org/W2053543045","https://openalex.org/W2055543087","https://openalex.org/W2055606526","https://openalex.org/W2071813692","https://openalex.org/W2074454485","https://openalex.org/W2083792370","https://openalex.org/W2091363481","https://openalex.org/W2092771702","https://openalex.org/W2096104385","https://openalex.org/W2096254008","https://openalex.org/W2096691209","https://openalex.org/W2100082529","https://openalex.org/W2101760255","https://openalex.org/W2114046957","https://openalex.org/W2115170812","https://openalex.org/W2136802843","https://openalex.org/W2145188374","https://openalex.org/W2148149002","https://openalex.org/W2152474929","https://openalex.org/W2152792488","https://openalex.org/W2154011558","https://openalex.org/W2156370341","https://openalex.org/W2166858780","https://openalex.org/W2168040684","https://openalex.org/W2177293834","https://openalex.org/W2226490553","https://openalex.org/W2248478085","https://openalex.org/W2315349515","https://openalex.org/W2341550006","https://openalex.org/W2341557816","https://openalex.org/W2411253336","https://openalex.org/W3143485855","https://openalex.org/W4237646515","https://openalex.org/W4247338812"],"related_works":["https://openalex.org/W1996510283","https://openalex.org/W2233982393","https://openalex.org/W2476270710","https://openalex.org/W75377399","https://openalex.org/W2944551704","https://openalex.org/W4225078532","https://openalex.org/W4241399311","https://openalex.org/W2112653328","https://openalex.org/W2954462030","https://openalex.org/W2528156923"],"abstract_inverted_index":{"Cytotoxic":[0],"chemotherapy":[1,15,37,171],"suppresses":[2],"the":[3,12,21,29,50,70,77,93,191,201,216,220],"hematopoietic":[4],"system,":[5],"impairing":[6],"host":[7],"protective":[8],"mechanisms":[9],"and":[10,40,62,65,67,102,105,123,154,178,184,218],"limiting":[11],"doses":[13],"of":[14,31,72,79,97,176,193],"that":[16,42,112,133],"can":[17],"be":[18],"tolerated.":[19],"Neutropenia,":[20],"most":[22],"serious":[23],"hematologic":[24],"toxicity,":[25],"is":[26],"associated":[27,118,168],"with":[28,81,86,119,169,210],"risk":[30,131,153,192,209],"life-threatening":[32],"infections":[33],"as":[34,36,92,160],"well":[35],"dose":[38],"reductions":[39],"delays":[41],"may":[43,134,196],"compromise":[44],"treatment":[45,182],"outcomes.":[46],"The":[47],"authors":[48],"reviewed":[49],"recent":[51],"literature":[52],"to":[53,129,137,146,155,204],"provide":[54],"an":[55,144],"update":[56],"on":[57],"research":[58,126],"in":[59,143,189,200],"chemotherapy-induced":[60],"neutropenia":[61,101,113],"its":[63,90,103],"complications":[64,167,195],"impact,":[66],"they":[68],"discuss":[69],"implications":[71],"this":[73],"work":[74],"for":[75],"improving":[76],"management":[78],"patients":[80,136,150,206],"cancer":[82],"who":[83],"are":[84,151,172],"treated":[85],"myelosuppressive":[87,170],"chemotherapy.":[88],"Despite":[89],"importance":[91],"primary":[94],"dose-limiting":[95],"toxicity":[96],"chemotherapy,":[98],"much":[99],"concerning":[100],"consequences":[104],"impact":[106],"remains":[107,114],"unknown.":[108],"Recent":[109],"surveys":[110],"indicate":[111],"a":[115,173],"prevalent":[116],"problem":[117],"substantial":[120],"morbidity,":[121],"mortality,":[122,179],"costs.":[124,187,221],"Much":[125],"has":[127],"sought":[128],"identify":[130],"factors":[132],"predispose":[135],"neutropenic":[138,194],"complications,":[139],"including":[140],"febrile":[141],"neutropenia,":[142],"effort":[145],"predict":[147],"better":[148],"which":[149],"at":[152,207],"use":[156],"preventive":[157,212],"strategies,":[158,213],"such":[159],"prophylactic":[161],"colony-stimulating":[162],"factors,":[163],"more":[164],"cost-effectively.":[165],"Neutropenic":[166],"significant":[174],"cause":[175],"morbidity":[177],"possibly":[180],"compromised":[181],"outcomes,":[183],"excess":[185],"healthcare":[186],"Research":[188],"quantifying":[190],"make":[197],"it":[198],"possible":[199],"near":[202],"future":[203],"target":[205],"greater":[208],"appropriate":[211],"thereby":[214],"maximizing":[215],"benefits":[217],"minimizing":[219]},"counts_by_year":[{"year":2026,"cited_by_count":50},{"year":2025,"cited_by_count":49},{"year":2024,"cited_by_count":67},{"year":2023,"cited_by_count":63},{"year":2022,"cited_by_count":59},{"year":2021,"cited_by_count":72},{"year":2020,"cited_by_count":67},{"year":2019,"cited_by_count":41},{"year":2018,"cited_by_count":40},{"year":2017,"cited_by_count":46},{"year":2016,"cited_by_count":50},{"year":2015,"cited_by_count":36},{"year":2014,"cited_by_count":40},{"year":2013,"cited_by_count":36},{"year":2012,"cited_by_count":29}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}